DE69330417T2 - Verfahren zur testung von blutkonserven auf virale verunreinigung - Google Patents

Verfahren zur testung von blutkonserven auf virale verunreinigung

Info

Publication number
DE69330417T2
DE69330417T2 DE69330417T DE69330417T DE69330417T2 DE 69330417 T2 DE69330417 T2 DE 69330417T2 DE 69330417 T DE69330417 T DE 69330417T DE 69330417 T DE69330417 T DE 69330417T DE 69330417 T2 DE69330417 T2 DE 69330417T2
Authority
DE
Germany
Prior art keywords
testing
blood unit
viral
present
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69330417T
Other languages
English (en)
Other versions
DE69330417D1 (de
Inventor
R Chapman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of DE69330417D1 publication Critical patent/DE69330417D1/de
Publication of DE69330417T2 publication Critical patent/DE69330417T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D17/00—Separation of liquids, not provided for elsewhere, e.g. by thermal diffusion
    • B01D17/02—Separation of non-miscible liquids
    • B01D17/0217—Separation of non-miscible liquids by centrifugal force
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/0012—Settling tanks making use of filters, e.g. by floating layers of particulate material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/24—Feed or discharge mechanisms for settling tanks
    • B01D21/2405—Feed mechanisms for settling tanks
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/24—Feed or discharge mechanisms for settling tanks
    • B01D21/2444—Discharge mechanisms for the classified liquid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/24—Feed or discharge mechanisms for settling tanks
    • B01D21/245—Discharge mechanisms for the sediments
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/26—Separation of sediment aided by centrifugal force or centripetal force
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/491—Blood by separating the blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2221/00—Applications of separation devices
    • B01D2221/10—Separation devices for use in medical, pharmaceutical or laboratory applications, e.g. separating amalgam from dental treatment residues
DE69330417T 1992-02-10 1993-02-09 Verfahren zur testung von blutkonserven auf virale verunreinigung Expired - Fee Related DE69330417T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83328592A 1992-02-10 1992-02-10
PCT/US1993/001167 WO1993016201A1 (en) 1992-02-10 1993-02-09 Method for testing blood units for viral contamination

Publications (2)

Publication Number Publication Date
DE69330417D1 DE69330417D1 (de) 2001-08-16
DE69330417T2 true DE69330417T2 (de) 2002-05-29

Family

ID=25263984

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330417T Expired - Fee Related DE69330417T2 (de) 1992-02-10 1993-02-09 Verfahren zur testung von blutkonserven auf virale verunreinigung

Country Status (12)

Country Link
US (1) US5498520A (de)
EP (1) EP0587832B1 (de)
JP (2) JPH06507078A (de)
AT (1) ATE203058T1 (de)
AU (1) AU665409B2 (de)
CA (1) CA2107798C (de)
DE (1) DE69330417T2 (de)
ES (1) ES2161228T3 (de)
MX (1) MX9300705A (de)
NO (1) NO933612D0 (de)
WO (1) WO1993016201A1 (de)
ZA (1) ZA93918B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
US5834660A (en) * 1995-04-10 1998-11-10 Alpha Therapeutic Corporation Method and system for testing blood samples
US5780222A (en) * 1995-04-10 1998-07-14 Alpha Therapeutic Corporation Method of PCR testing of pooled blood samples
US5591573A (en) * 1995-04-10 1997-01-07 Alpha Therapeutic Corporation Method and system for testing blood samples
US6844158B1 (en) * 1997-12-22 2005-01-18 Hitachi Chemical Co., Ltd. Direct RT-PCR on oligonucleotide-immobilized PCR microplates
SE0001132D0 (sv) * 2000-03-29 2000-03-29 Cavidi Tech Ab Method of concentrating and recovering a viral enzyme activity from biological samples
AU2001286499A1 (en) * 2000-08-16 2002-02-25 Matthew Baker Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies
US7422860B2 (en) 2001-02-07 2008-09-09 Massachusetts Institute Of Technology Optoelectronic detection system
US8216797B2 (en) 2001-02-07 2012-07-10 Massachusetts Institute Of Technology Pathogen detection biosensor
US20040259076A1 (en) * 2003-06-23 2004-12-23 Accella Scientific, Inc. Nano and micro-technology virus detection method and device
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
EP2410335A1 (de) * 2005-11-30 2012-01-25 Massachusetts Institute of Technology (MIT) Biosensor zur Erkennung von Krankheitserregern
CN114452684A (zh) * 2020-11-10 2022-05-10 菲尔德森(江苏)生物技术有限公司 一种富血小板血浆提取分离套装及提取方法
DE102021203409A1 (de) * 2021-04-07 2022-10-13 Robert Bosch Gesellschaft mit beschränkter Haftung Verfahren zum Nachweis aktiver Viren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707439A (en) * 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US5175270A (en) * 1986-09-10 1992-12-29 Polyprobe, Inc. Reagents for detecting and assaying nucleic acid sequences
US4908318A (en) * 1987-09-04 1990-03-13 Integrated Genetics, Inc. Nucleic acid extraction methods
AU7954691A (en) * 1990-05-01 1991-11-27 American National Red Cross, The Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
EP0502213B1 (de) * 1990-09-25 2003-03-19 Asahi Medical Co., Ltd. Methode und filtersystem zur entfernung von leukozyten

Also Published As

Publication number Publication date
EP0587832B1 (de) 2001-07-11
ZA93918B (en) 1993-10-22
MX9300705A (es) 1993-09-01
EP0587832A4 (en) 1998-07-29
ES2161228T3 (es) 2001-12-01
AU665409B2 (en) 1996-01-04
NO933612L (no) 1993-10-08
AU3616193A (en) 1993-09-03
CA2107798C (en) 1996-04-02
WO1993016201A1 (en) 1993-08-19
NO933612D0 (no) 1993-10-08
JPH06507078A (ja) 1994-08-11
US5498520A (en) 1996-03-12
CA2107798A1 (en) 1993-08-11
ATE203058T1 (de) 2001-07-15
DE69330417D1 (de) 2001-08-16
JP2002204700A (ja) 2002-07-23
EP0587832A1 (de) 1994-03-23

Similar Documents

Publication Publication Date Title
DE69330417T2 (de) Verfahren zur testung von blutkonserven auf virale verunreinigung
DE3580973D1 (de) Geraet zur bestrahlung von blutteilen.
DE69032500D1 (de) Verfahren und vorrichtung zur behandlung von blut für die menschliche transfusion
DE3856587D1 (de) Vorrichtung und Verfahren zur Verminderung des Leukocytengehalts von Blutkomponenten
DE68917462D1 (de) Vorrichtung und verfahren zum sammeln und gefrieren von blutplasma.
FI99192B (fi) Menetelmä virusten inaktivoimiseksi veressä ja verituotteissa
DE68902698D1 (de) Verfahren zur trennung von blut in blutkomponenten und einheit zur trennung von blutkomponenten.
CA2074830A1 (en) Systems and methods for simultaneously removing free and entrained contaminants in fluid like blood using photoactive therapy and cellular separation techniques
DE69409164T2 (de) Vorrichtung zur Trennung von Leukozyten oder Leukozyten und Plättchen und Filter dafür
DE69129419D1 (de) Gerät und Verfahren zur Trennung von Blutbestandteilen aus Vollblut
DE69107756T2 (de) Vorrichtung und Verfahren zur Evakuierung von Blutentnahmeröhrchen.
DE59308561D1 (de) Verfahren und Vorrichtung zum Feststellen der Filtrationswirkung von Filtern bei der Sterilluftaufbereitung
DE3687453T2 (de) Einrichtung zur filtration von plasma aus blut.
DE3855127D1 (de) Methode zur Entfernung von Granulozyten aus dem Blut und Gerät dafür
CN1249952A (zh) 血浆病毒灭活的方法及其装置
DE69932151D1 (de) Verfahren und vorrichtung zum transformieren von plasma
ATE177350T1 (de) Vorrichtung zur reinigung von schwermetalle enthaltendem bodenmaterial
ATE80729T1 (de) Verfahren und vorrichtung zum konzentrieren makromolekularer loesungen.
ATE62082T1 (de) Optimaler parametrischer signalprozessor zur filterung mit endlichem impulsresponse nach der methode der kleinsten quadratischen abweichung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee